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background:  Diabetic patients are known to have increased sympathetic activity which can lead to hypertension. In a recent study, improved 
glucose control was observed among hypertensive diabetic patients undergoing renal denervation (RDN). The aim of this study was to investigate the 
role of RDN on glucose control, blood pressure, and cardiac and renal function in an animal model of diabetes with hypertension.
methods: Streptozotocin-induced diabetic homozygous Ren2 rats received sham surgery (n=10) or RDN (n=7) and were followed for 6 weeks. 
RDN was performed by surgically removing the adventitia of renal arteries and veins and coating them with a solution of 10% phenol in ethanol. 
Blood pressure (BP) was assessed in conscious rats; insulin sensitivity was assessed according to the Homeostasis Model Assessment (HOMA); renal 
function measured by direct glomerular filtration rate (GFR); sodium and potassium excretion measured; and hemodynamic measures assessed.
results: In diabetic Ren2 rats, RDN increased insulin sensitivity (Sham 6.9 ± 1.1, RDN 12.6 ± 2.7 %S, P<0.05), reduced end systolic pressure in 
anesthetized animals (Sham 153 ± 7, RDN 124 ± 5 mmHg, P<0.01) and non-significantly lowered BP in conscious animals (Sham 161 ± 9, RDN 
145 ± 12 mmHg, P>0.05). Hyper-filtration in diabetic animals was reduced (Sham 15.6 ± 0.2, RDN 13.3 ± 0.7 ml/min/kg, P<0.01) accompanied 
by increased urine volume (Sham 95 ± 8, RDN 129 ± 13 ml, P<0.05), and significantly increased sodium (Sham 2.0 ± 0.2, RDN 3.4 ± 0.5 mmol/
day, P<0.01) and potassium (Sham 3.8 ± 0.2, RDN 5.5 ± 0.9 mmol/day, P<0.05) excretion. Blood glucose was unaltered.
conclusions: RDN enhanced insulin sensitivity accompanied by reduced BP and increased sodium excretion in Ren2 diabetic rats. In addition to 
BP reduction, these findings suggest a potentially important role of RDN in glycemic control in hypertensive diabetic patients.
